New diabetes clinical trial: SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke
Published on: August 05, 2025 at 11:00PM
Conditions: Acute Ischemic Stroke
Interventions: Drug: SGLT-2 inhibitors; Other: Standard medical treatment
Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
https://ift.tt/gb4knzf
Conditions: Acute Ischemic Stroke
Interventions: Drug: SGLT-2 inhibitors; Other: Standard medical treatment
Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
https://ift.tt/gb4knzf
Comments
Post a Comment